Evidence map›Paper›PMID 32705504›Full record

Trial reportHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2020

Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Levels in Hypertensive Patients: Speckle Tracking Echocardiography.

Ibtsam Khairat, Lamiaa Khedr, Rehab Werida

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ibtsam KhairatDepartment of Cardiology, Faculty of Medicine, Tanta University, El-Gharbia, Egypt.
Lamiaa KhedrDepartment of Cardiology, Faculty of Medicine, Tanta University, El-Gharbia, Egypt.
Rehab WeridaDepartment of Clinical Pharmacy, Faculty of Pharmacy, Damanhour University, El-Behaira, 22511, Egypt. rehabwrieda@pharm.dmu.edu.eg.ORCID http://orcid.org/0000-0002-5983-3993
Tanta University Hospital · EGDamanhour University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStructural and functional properties of the left ventricle (LV) wall have been reported to be altered in hypertension, even at early stages of the disease. Abnormal adipokine levels affect blood pressure regulation. Hypo-adiponectinaemia and hyper-leptinaemia were reported in hypertension.

aimTo evaluate the effects of valsartan versus amlodipine on LV deformation also, on plasma adiponectin and leptin levels in hypertensive individuals.

methodsLV strain was measured by two-dimensional speckle tracking echocardiography, plasma levels of adiponectin and leptin was determined in 30 healthy individuals served as control group and in 200 hypertensive patients before and after treatment for 6 months with either valsartan 160 mg or amlodipine 10 mg.

resultsCompared to control group longitudinal strain was significantly affected in hypertensive patients, adiponectin was significantly lower while TNF-α, hs-CRP and leptin levels were significantly higher in hypertensive group. A significant improvement in LV functions, along with a decrease in leptin and increase in adiponectin levels in valsartan group compared to amlodipine group.

conclusionsOur results indicate that valsartan is superior to amlodipine when it comes to affecting the hormonal function of human adipose tissue. Valsartan has a beneficial effect on LV deformation and function presented in GLS.

Indexed as

EchocardiographyAdipokinesAdiponectinAdultAmlodipineAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBiomarkersCalcium Channel BlockersC-Reactive ProteinEgyptFemaleHumansHypertensionLeptinMaleAdipokinesAdiponectinADIPOQ protein, humanAmlodipineAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBiomarkersCalcium Channel BlockersC-Reactive ProteinLEP protein, humanLeptinTNF protein, humanTumor Necrosis Factor-alphaValsartanAmlodipineGLSHypertensionTwo-dimensional strainValsartan

Identifiers

PMID32705504
OpenAlexW3044813202

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.